EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS)’s Basic Consolidated EPS Came In At $-2.2942

0

EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) posted annual consolidated EPS of $-2.2942 for the period ended 2015-12-31. But basic consolidated EPS for the quarter period ended 2015-12-31 came in at $-2.2942.

Basic EPS from continuing operations

The company’s basic EPS from continuing operations for the annual period ended 2015-12-31 came in at $-2.2942 while basic EPS from continuing operations for the three-month period to 2015-12-31 was$-2.2942.

EPS contribution from parent

EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) received $-2.2942 basic EPS contribution from its parent company in the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, the parent company contributed EPS of $-2.2942.

Basic net EPS

EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) posted basic net EPS of $-2.29 for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, the company posted basic net EPS of $-2.29.

Consolidated diluted EPS

The company’s consolidated diluted EPS for the period ended 2015-12-31 was $-2.2942 while consolidated diluted EPS was $-2.2942 for the quarter ended 2015-12-31.

Basic diluted EPS

Basic diluted EPS from continuing operation for the annual period ended 2015-12-31 was $-2.2942. As for the quarter, diluted EPS from continuing operations for the three-month ended 2015-12-31 stood at $-2.2942.

Net diluted EPS

Net diluted EPS was $-2.29 for the annual period ended 2015-12-31. But net diluted EPS for the quarterly period ended 2015-12-31 stood at $-2.29.

Diluted EPS from parent

From the parent company, EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) received diluted EPS of $-2.2942

For the annual period ended 2015-12-31, diluted EPS from EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS)’s parent company was$-2.2942. But for the quarter period ended 2015-12-31, diluted EPS contribution from the parent company was $-2.2942.

EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS)’s net basic EPS for the annual period ended 2015-12-31 was $-2.3 and for the quarter period ended 2015-12-31 it was $-2.3.

For the annual period ended 2015-12-31, the company had average basic shares outstanding of 22.748 while basic shares outstanding were 22.748 for the quarter period ended 2015-12-31.

The company’s diluted shares outstanding was 22.748 for the annual period ended 2015-12-31 is 22.748. That compared with 22.748 diluted shares outstanding for the quarter period ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 7 times, 1 visits today)